Levomethamphetamine

Levomethamphetamine

Salts []
Levomethamphetamine hydrochloride

Molecular structure via molpic based on CDK

Physical properties []
Molecular mass	149.23 g/mol ^[1]
Predicted LogP	2.1 ^[1]

Structural Identifiers []
Molecular formula	C₁₀H₁₅N ^[1]
IUPAC name	(2R)-N-methyl-1-phenylpropan-2-amine ^[1]
SMILES	C[C@H](CC1=CC=CC=C1)NC ^[1]
InChI	InChI=1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3/t9-/m1/s1 ^[1]
InChIKey	MYWUZJCMWCOHBA-SECBINFHSA-N ^[1]

Pharmacokinetics[]
Elimination half-life	10 – 15 hours

Levomethamphetamine (also known as Levmetamfetamine, Methamphetamine, Methylamphetamine, levomethamphetamine, R(-)-N-Methylamphetamine, 1-Phenyl-2-methylaminopropane, Vicks, Levmetamfetamine cii, NSC 6084 or levmetanfetamina) is a stimulant substance of the amphetamine class.

Chemistry

Salts []

Levomethamphetamine is typically found in the form of its hydrochloride salt.

Stereochemistry []

Levomethamphetamine is a absolute mixture.

Subjective effects []

class / Stimulant

Physical effects
Abnormal heartbeat Appetite suppression Dehydration Dry mouth Increased blood pressure Increased heart rate Increased libido Restless legs Shakiness Stamina enhancement Stimulation Teeth grinding Vasoconstriction

Cognitive effects
Analysis enhancement Cognitive euphoria Compulsive redosing Disinhibition Ego inflation Focus enhancement Increased music appreciation Mania Motivation enhancement Suggestibility suppression Thought acceleration Wakefulness

Legal status []

Australia: Levomethamphetamine is a S8 substance.
Brazil: Levomethamphetamine is a F2 substance.^[3]
Canada: Levomethamphetamine is a Schedule I substance.
United Kingdom: Levomethamphetamine is a Class A substance.
United States: Levomethamphetamine is a Schedule I under the "Controlled Substances Act (CSA)".
United Nations: Levomethamphetamine is a Schedule II substance.
Germany: Levomethamphetamine is a Anlage II substance.

External links []

References []

National Center for Biotechnology Information. PubChem Compound Summary for CID 36604, Levmetamfetamine. Accessed April 29, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/36604
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Levomethamphetamine. UNII: Y24T9BT2Q2. Global Substance Registration System. Accessed April 29, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/Y24T9BT2Q2
Anvisa. RDC Nº 877 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. May 28, 2024. Accessed April 29, 2026. https://www.in.gov.br/en/web/dou/-/resolucao-da-diretoria-colegiada-anvisa-n-877-de-28-de-maio-de-2024-562758149

AnodyneWiki